racemetirosine has been researched along with Chemodectoma in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schuppert, F | 1 |
| Scheumann, GF | 1 |
| Schöber, C | 1 |
| Overbeck, J | 1 |
| Schürmeyer, TH | 1 |
| Schmoll, HJ | 1 |
| Dralle, H | 1 |
| von zur Mühlen, A | 1 |
1 other study available for racemetirosine and Chemodectoma
| Article | Year |
|---|---|
[Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl--a case report].
Topics: Adult; alpha-Methyltyrosine; Aorta, Abdominal; Combined Modality Therapy; Dopamine; Epinephrine; Hum | 1991 |